References

1. Green, K. L. and Grant, K. A. (1998) Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol. Drug Alcohol Depend. 52, 49-59.

2. Krystal, J. H. and Tabakoff, B. (2001) Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications, in Psychopharmacology: A Fifth Generation of Progress.

3. Charney, D. S., Nestler, E., and Bunney, B. S. (1999) Neurobiology of Mental Illness, Oxford University Press, New York.

4. Grant, K. A. and Lovinger, D. M. (1995) Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes. Clin. Neurosci. 3, 155-164.

5. Krystal, J. H., Belger, A., Abi-Saab, W., Moghaddam, B., Charney, D. S., Anand, A., et al. (2000). Glutamatergic contributions to cognitive dysfunction in schizophrenia, in Cognitive Functioning in Schizophrenia (Harvey, P. D. and Sharma, T., eds.), Oxford University Press, London.

6. Sucher, N. J., Awobuluyi, M., Choi, Y. B., and Lipton, S. A. (1996) NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17, 348-355.

7. Lovinger, D. M., White, G., and Weight, F. F. (1989) Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243,1721-1724.

8. Hoffman, P. L., Rabe, C. S., Grant, K. A., Valverius, P., Hudspith, M., and Tabakoff, B. (1990) Ethanol and the NMDA receptor. Alcohol 7, 229-231.

9. Grant, K. A. and Colombo, G. (1993) Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-d-aspartate antagonists. Pharmacol. Exp. Ther. 264,1241-1247.

10. Luby, E. D., Cohen, B. D., Rosenbaum, G., Gottlieb, J. S., and Kelley, R. (1959) Study of a new schizophrenomimetic drug—sernyl. Arch. Neurol. Psychiatry 81, 363-369.

11. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry. 51, 199-214.

12. Krystal, J. H., Petrakis, I. L., Webb, E., Cooney, N. L., Karper, L. P., Namanworth, S., et al. (1998) Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry 55, 354-360.

13. Schutz, C. G. and Soyka, M. (2000) Dextromethorphan challenge in alcohol-dependent patients and controls [letter; comment.] Arch. Gen. Psychiatry 57, 291-292.

14. Krystal, J. H., Petrakis, I. L., Webb, E., Cooney, N. L., Karper, L. P., Namanworth, S., et al. (1998). Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. Arch. Gen. Psychiatry 55, 354-360.

15. Krystal, J. H., D'Souza, D. C., Karper, L. P., Bennett, A., Abi-Dargham, A., Abi-Saab, D., et al. (1999) Interactive effects of subanesthetic ketamine and haloperidol. Psychopharmacology 145, 193-204.

16. Krystal, J. H. and Petrakis, I. L. (2000) Dextromethorphan challenge in alcohol dependent patients and controls—reply. Arch. Gen. Psychiatry 57, 292.

17. Perez-Reyes, M., White, W. R., McDonald, S. A., and Hicks, R. E. (1992) Interaction between ethanol and dextroamphetamine: effects on psychomotor performance. Alcohol. Clin. Exp. Res. 16, 75-81.

18. Madonick, S. M., D'Souza, D. C., Brush, L., Cassello, K., Wray, Y., Larvey, K., et al. (1999) Naltrexone blockade of ketamine intoxication in healthy humans. Alcohol. Clin. Exp. Res. 23(Suppl.) 103A (abstract).

19. Swift, R. M., Whelihan, W., Kuznetsov, O., Buongiorno, G., and Hsuing, H. (1994) Naltrexone-induced alterations in human ethanol intoxication. Am. J. Psychiatry. 151,1463-1467.

20. Krystal, J. H., Karper, L. P., Bennett, A., D'Souza, D. C., Abi-Dargham, A., Morrissey, K., et al. (1998) Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology 135, 213-229.

21. Anand, A., Charney, D. S., Cappiello, A., Berman, R. M., Oren, D. A., and Krystal, J. H. (2000) Lamotrigine attenuates ketamine effects in humans: support for hyperglutamatergic effects of NMDA antagonists. Arch. Gen. Psychiatry 57, 270-276.

22. Krupitsky, E., Burakov, A., Romanova, T., Grinenko, N., Grinenko, A., Vegso, S., et al. (2000) Interactive ethanol-like cognitive and behavioral effects of nimodipine and ketamine in abstinent alcoholics. Alcohol. Clin. Exp. Res. 24, 12A.

23. D'Souza, D. C., Gil, R., Cassello, K., Morrissey, K., Abi-Saab, D., White, J., et al. (2000) IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healty humans. Biol. Psychiatry 47, 450-462.

24. D'Souza, D. C., Gil, R., Zuzarte, E., Abi-Saab, D., Damon, D., White, et al. (1997) Glycine ketamine interactions in healthy humans. Schizophr. Res. 24, 213.

25. Krystal, J., Petrakis, I., Krasnicki, S., Trevisan, L., Boutros, N., and D'Souza, D. C. (1998) Altered responses to agonists of the strychnine-insensitive glycine NMDA coagonist (SIGLY) site in recently detoxified alcoholics. Alcohol. Clin. Exp. Res. 22, 94A.

26. D'Souza, D. C., Charney, D. S., and Krystal, J. H. (1995) Glycine site agonists of the NMDA receptor: a review. CNSDrug Rev. 1, 227-260.

27. Trevisan, L., Nammanworth, S., Petrakis, I., Randall, P., Charney, D. S., and Krystal, J. H. (1995) Cycloserine modulation of human ethanol intoxication: implications for NMDA receptor contributions to human ethanol intoxication. Alcohol. Clin. Exp. Res. 19, 4A(abstract).

28. Mason, B. J. (2001) Results of the multicenter study of acamprosate in the treatment of alcoholism. Biol. Psychiatry 49, 77S.

29. Sass, H., Soyka, M., Mann, K., and Zieglgansberger, W. (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence [published erratum appears in Arch. Gen. Psychiatry 53(12): 1097.] Arch. Gen. Psychiatry 53, 673-680.

30. Popp, R. L. and Lovinger, D. M. (2000) Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons. Eur. J. Pharmacol. 394, 221-231.

31. Schneider, U., Wohlfarth, K., Schulze-Bonhage, A., Haacker, T., Muller-Vahl, K. R., Zedler, M., et al. (1999) Effects of acamprosate on memory in healthy young subjects. J. Studies Alcohol 60,172-175.

32. Grant, K. A. and Woolverton, W. L. (1989) Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals. Pharmacol. Biochem. Behav. 32, 607-611.

33. Reynolds, I. J., and Miller, R. J. (1988) Trcyclic antidepressants block N-methyl-d-aspartate receptors: similarities to the action of zinc. Br. J. Pharmacol. 95, 95-102.

34. Mason, B. J., Kocsis, J. H., Ritvo, E. C., and Cutler, R. B. (1996) A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression [see comments.] JAMA 275, 761-767.

35. Tsai, G. and Coyle, J. T. (1998) The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Ann. Rev. Med. 49,173-184.

36. Grant, K. A., Snell, L. D., Rogawski, M. A., Thurkauf, A., and Tabakoff, B. (1992) Comparison of the effects of the uncompetitive N-methyl-d-aspartate antagonist (+-)-5-aminocarbonyl-10, 11-dihydro-5ff-dibenzo[a,d] cyclohepten-5, 10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260, 1017-1022.

37. Valverius, P., Crabbe, J., Hoffman, P., and Tabakoff, B. (1990) NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. Eur. J. Pharmacol. 184, 185-189.

38. Hemmingsen, R., Braestrup, C., Nielsen, M., and Barry, D. L. (1982) The benzodiazepine/GABA receptor complex during severe ethanol intoxication and withdrawal in the rat. Acta Psychiatr. Scand. 65,120-126.

39. Harris, R. A., Valenzuela, C. F., Brozowski, S., Chuang, L., Hadingham, K., and Whiting, P. J. (1998) Adaptation of gamma-aminobutyric acid type A receptors to alcohol exposure: studies with stably transfected cells. J. Pharmacol. Exp. Ther. 284, 180-188.

40. Schiller, J., Schiller, Y., and Clapham, D. E. (1998) NMDA receptors amplify calcium influx into dendritic spines during associative pre-and postsynaptic activation. Nature Neurosci. 1, 114-118.

41. Hoffman, P. L., Grant, K. A., Snell, L. D., Reinlib, L., Iorio, K. and Tabakoff, B. (1992) NMDA receptors: role in ethanol withdrawal seizures. Ann. NY Acad. Sci. 654, 52-60.

42. Hoffman, P. L. (1995) Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab. Brain Dis. 10, 73-79.

43. Michaelis, E. K., Freed, W. J., Galton, N., Foye, J., Michaelis, M. L., Phillips, I., et al. (1990) Glutamate receptor changes in brain synaptic membranes from human alcoholics. Neurochem. Res. 15, 1055-1063.

44. Freund, G. and Anderson, K. J. (1996) Glutamate receptors in the frontal cortex of alcoholics. Alcohol. Clin. Exp. Res. 20, 1165-1172.

45. Tsai, G. E., Ragan, P., Chang, R., Chen, S., Linnoila, V. M., and Coyle, J. T., (1998) Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am. J. Psychiatry 155, 726-732.

46. Keller, E., Cummins, J. T., and von Hungen, K. (1983) Regional effects of ethanol on glutamate levels, uptake and release in slice and synaptosome preparations from rat brain. Subst. Alcohol Actions/Misuse 4, 383-392.

47. Tsai, G., Gastfriend, D. R., and Coyle, J. T. (1995) The glutamatergic basis of human alcoholism. Am. J. Psychiatry 15, 332-340.

48. Krystal, J. H., Webb, E., Grillon, C., Cooney, N., Casal, L., Morgan, C. A., 3rd, et al. (1997) Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP). Psychopharmacology 131, 207-215.

49. Brown, M. E., Anton, R. F., Malcolm, R., and Ballenger, J. C. (1988) Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol. Psychiatry 23, 507-514.

50. Lechtenberg, R. and Worner, T. M. (1992) Total ethanol consumption as a seizure risk factor in alcoholics. Acta Neurol. Scand. 85, 90-94.

51. Malcolm, R., Herron, J. E., Anton, R. F., Roberts, J., and Moore, J. (2000) Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale. Alcohol 20, 181-185.

52. De Soto, C. B., O'Donnell, W. E., Allred, L. J., and Lopes, C. E. (1985) Symptomatology in alcoholics at various stages of abstinence. Alcohol. Clin. Exp. Res. 9, 505-512.

53. Behar, K., Rothman, D., Petersen, K., Hooten, M., Namanworth, S., Delaney, R., et al. (1999) Preliminary evidence of reduced cortical GABA levels in localized 1H NMR spectra of alcohol dependent and hepatic encephalopathy patients. Am. J. Psychiatry 156, 952-954.

54. Adams, K. M., Gilman, S., Koeppe, R. A., Kluin, K. J., Brunberg, J. A., Dede, D., et al. (1993) Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcohol. Clin. Exp. Res. 17, 205-210.

55. Volkow, N. D., Wang, G. J., Hitzemann, R., Fowler, J. S., Overall, J. E., Burr, G., et al. (1994) Recovery of brain glucose metabolism in detoxified alcoholics. Am. J. Psychiatry 15,178-183.

56. Volkow, N. D., Hitzemann, R., Wang, G. J., Fowler, J. S., Burr, G., Pascani, K., et al. (1992) Decreased brain metabolism in neurologically intact healthy alcoholics. Am. J. Psychiatry 149, 1016-1022.

57. Krystal, J., Karper, L., D'Souza, D. C., Webb, E., Bennett, A., Abi-Dargham, A., et al. (1995) Differentaiating NMDA dys-regulation in schizophrenia and alcoholism using ketamine. Schizophr. Res. 15, 156.

58. Krystal, J., Petrakis, I., Krasnicki, S., Trevisan, L., Boustros, N., and D'Souza, D. C. (1999) Altered responses to agonists of the strychnine-insensitive glycine NMDA coagonist (SIGLY) site in recently detoxified alcoholics. Alcohol. Clin. Exp. Res. 22, 94A.

59. Pfefferbaum, A., Sullivan, E. V., Rosenbloom, M. J., Mathalon, D. H., and Lim, K. O. (1998) A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch. Gen. Psychiatry 55, 905-912.

60. Pfefferbaum, A., Sullivan, E. V., Mathalon, D. H., and Lim, K. O. (1997) Frontal lobe volume loss observed with magnetic resonance imaging in older chronic alcoholics. Alcohol. Clin. Exp. Res. 21, 521-529.

61. De Bellis, M. D., Clark, D. B., Beers, S. R., Soloff, P. H., Boring, A. M., Hall, J., et al. (2000) Hippocampal volume in adolescent-onset alcohol use disorders. Am. J. Psychiatry 157, 737-744.

62. Parsons, O. A. and NIxon, S. J. (1993) Neurobehavioral sequelae of alcoholism. Neurol. Clin. 11, 205-218.

63. Schafer, K., Butters, N., Smith, T., Irwin, M., Brown, S., Hanger, P., et al. (1991) Cognitive performance of alcoholics: a longitudinal evaluation of the role of drinking history, depression, liver function, nutrition, and family history. Alcohol. Clin. Exp. Res. 15, 653-660.

64. Goff, D., Berman, I., Posever, T., Leahy, L., and Lynch, G. (1999). A preliminary dose-escalation trial of CX-516 (ampakine) added to clozapine in schizophrenia. Schizophr. Res. 36, 280.

65. Springer, J. E., Gwag, B. J., and Sessler, F. M. (1994), Central administration of the excitotoxin ALmethyl-d-aspartate increases nerve growth factor mRNA in vivo. Neurotoxicology 15, 483-489.

66. Heisenberg, C. P., Cooper, J. D., Berke, J., and Sofroniew, M. V. (1994). NMDA potentiates NGF-induced sprouting of septal cholinergic fibres. NeuroReport 5, 413-416.

67. Favaron, M., Manev, R. M., Rimland, J. M., Candeo, P., Beccaro, M., and Manev, H. (1993) NMDA-stimulated expression of BDNF mRNA in cultured cerebellar granule neurones. NeuroReport 4,1171-1174.

68. Lindefors, N., Ballarin, M., Ernfors, P., Falkenberg, T., and Persson, H. (1992) Stimulation of glutamate receptors increases expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Ann. NY Acad. Sci. 648, 296-299.

69. McLay, R. N., Freeman, S. M., Harlan, R. E., Ide, C. F., Kastin, A. J., and Zadina, J. E. (1997) Aging in the hippocampus: interrelated actions of neurotrophins and glucocorticoids. Neurosci. Biobehav. Rev. 21, 615-629.

70. Rylett, R. J. and Williams, L. R. (1994). Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. Trends Neurosci. 17, 486-490.

71. Petrakis, I. L., Boutros, N. N., O'Malley, S. M., Gelernter, J., and Krystal, J. H. (2000). NMDA dysregulation in individuals with a family vulnerability to alcoholism. Alcohol. Clin. Exp. Res. 24, 12A.

Beat Depression Today

Beat Depression Today

I know this is hard for you to believe. I mean, to be able to be totally free of depression in such little time... and without any effort... not to mention the freedom to live your life, appear hard to fulfill at first glance... That is until you know the facts On a subconscious level, you will experience an incredible and exclusive Tri- Enhanced trance state of hypnosis to reprogram your mind to free you from negatize emotions.

Get My Free Ebook


Post a comment